Research Analysts Set Expectations for CORT Q1 Earnings
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at Zacks Research lifted their Q1 2026 earnings per share (EPS) estimates for shares of Corcept Therapeutics in a report released on Wednesday, April 2nd. Zacks Research analyst K. Das now anticipates that the biotechnology company will post earnings per share of $0.47 for the […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at Zacks Research lifted their Q1 2026 earnings per share (EPS) estimates for shares of Corcept Therapeutics in a report released on Wednesday, April 2nd. Zacks Research analyst K. Das now anticipates that the biotechnology company will post earnings per share of $0.47 for the […]
